Endoscopy Supplies

Endoscopy Supplies EUSRA™ EUS-guided RFA Treatment

Category: RFA Treatment

esu guided rfa Treatment

Details and Features

  • Feasible and safe ablative treatment for locally advanced unresectable pancreatic cancer, neuroendocrine tumors, and cystic neoplasms
  • Easy approach to target lesions with a great pushability of the needle
  • Good echogenicity for safe procedure under EUS-guidance
  • Inner cooling system to ablate large volumes of tumor without tissue charring
  • A monopolar system
  • Compatible with VIVA Combo™ generators ONLY

Indication

Pancreatic tumor (locally advanced pancreatic cancer, pancreatic neuroendocrine tumor, pancreatic cysts, etc)

Extra pancreatic tumor (liver, adrenal, kidney, GI gyst, etc)

Key Resources

Product Information

Instructions

Key Resources

EUS-guided radiofrequency ablation of the porcine pancreas

Gastrointestinal Endoscopy Vol.76, No.5: 2012 Dong-Wan Seo, MD, PhD

Initial experience of EUS-guided radiofrequency ablation of unresectable pancreatic cancer

Gastrointestinal endsocopy 2015 Dong Wan Seo, MD, PhD

EUS-guided radiofrequency ablation for management of pancreatic insulinoma by using a novel needle electrode (with videos)

Gastrointestinal Endsocopy 2015 Sundeep Lakhtakia, MD, DM, MNAMS, FASGE

Endoscopic ultrasound-guided radiofrequency ablation of a pancreatic neuroendocrine tumor

Endsoscopy 2015 Elia Armellini, Stefano F. Crino, Marco Ballare, Pietro Occhipinti, MD, Italy

Electrode radiofrequency ablation EUS-guided-EUSRA™

Giornale Italiano Di Endoscopia Digestiva, Marzo 2017 Elia Armellini et al.

Cushing’s syndrome managed by endoscopic ultrasound-guided radiofrequency ablation of adrenal gland adenoma

Endoscopy 2017;49:E1-E2 Dong Wan Seo, MD, PhD

In the ever-evolving landscape of medical technology, one innovation stands out as a game-changer in the field of endoscopy: EUSRA™ – the Endoscopic Ultrasound-guided Radiofrequency Ablation (EUS-guided RFA) Treatment. This cutting-edge advancement promises a transformative approach to the diagnosis and treatment of various gastrointestinal conditions.

EUSRA™ combines the precision of endoscopic ultrasound with the therapeutic power of radiofrequency ablation to provide a minimally invasive solution for patients dealing with pancreatic cysts, tumors, and other complex gastrointestinal issues. Unlike traditional surgical methods, EUSRA™ offers reduced risk, shorter recovery times, and minimal discomfort.

This groundbreaking technology opens new doors for physicians and patients alike. With its ability to precisely target and treat abnormalities, EUSRA™ enables doctors to make more accurate diagnoses and formulate tailored treatment plans. Patients benefit from quicker procedures, less pain, and a faster return to their daily lives.

As medical science continues to push boundaries, EUSRA™ stands as a testament to human ingenuity, bringing hope to countless individuals facing gastrointestinal challenges. The future of endoscopy is here, and it’s called EUSRA™ – the beacon of progress in the world of medical innovation.